Home NDC 60940-024 Lonhala
Product NDC 60940-024
11-digit product format 609400024
Labeler code 60940
Product ID 60940-024_cf5a7a5b-ae64-0c3f-e053-2a95a90a150a
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Glycopyrrolate
Dosage form SOLUTION
Route RESPIRATORY (INHALATION)
Labeler Holopack Verpackungstechnik GmbH
Application NDA208437
Marketing category NDA
Marketing start 2017-12-05
Marketing end 0000-00-00
Substance GLYCOPYRROLATE
Active strength 25 ug/mL
Pharmacologic classes Anticholinergic [EPC],Cholinergic Antagonists [MoA]
NDC exclude flag No
Listing certified through 2022-12-31
Current FDA listing Historical FDA.report record Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N208437-001 LONHALA MAGNAIR KIT GLYCOPYRROLATE 25MCG/ML SOLUTION / INHALATION RLD 2017-12-05
Orange Book patents# Current patent rows page 1 of 1 · 9 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N208437-001 11278683 2026-08-16 Drug product 2022-03-25 N208437-001 9265900 2028-12-07 Drug product 2018-01-02 N208437-001 10940110 2029-02-26 U-1773 Drug product 2021-03-16 N208437-001 9789270 2030-10-30 Drug product 2018-01-02 N208437-001 9168556 2032-09-01 Drug product 2018-01-02 N208437-001 9604018 2033-05-16 Drug product 2018-01-02 N208437-001 10376661 2035-09-14 Drug product 2019-09-05 N208437-001 10688518 2036-11-12 Drug product 2020-06-30 N208437-001 10744277 2036-12-07 U-2941 Drug product 2020-09-01
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 45 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N208437-001 LONHALA MAGNAIR KIT 25MCG/ML SOLUTION / INHALATION RLD, RS 2017-12-05 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N208437-001 LONHALA MAGNAIR KIT 25MCG/ML SOLUTION / INHALATION RLD, RS 2017-12-05 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N208437-001 LONHALA MAGNAIR KIT 25MCG/ML SOLUTION / INHALATION RLD, RS 2017-12-05 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N208437-001 LONHALA MAGNAIR KIT 25MCG/ML SOLUTION / INHALATION RLD, RS 2017-12-05 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N208437-001 LONHALA MAGNAIR KIT 25MCG/ML SOLUTION / INHALATION RLD 2017-12-05 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 13 · 500 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-11-14 07:37:17 2026-10 N208437-001 11278683 2026-08-16 Drug product 2022-03-25 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N208437-001 9265900 2028-12-07 Drug product 2018-01-02 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N208437-001 10940110 2029-02-26 U-1773 Drug product 2021-03-16 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N208437-001 9789270 2030-10-30 Drug product 2018-01-02 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N208437-001 9168556 2032-09-01 Drug product 2018-01-02 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N208437-001 9604018 2033-05-16 Drug product 2018-01-02 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N208437-001 10376661 2035-09-14 Drug product 2019-09-05 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N208437-001 10688518 2036-11-12 Drug product 2020-06-30 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N208437-001 10744277 2036-12-07 U-2941 Drug product 2020-09-01 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N208437-001 11278683 2026-08-16 Drug product 2022-03-25 c2088c7a36db…2026-10-15 13:18:30 2026-09 N208437-001 9265900 2028-12-07 Drug product 2018-01-02 c2088c7a36db…2026-10-15 13:18:30 2026-09 N208437-001 10940110 2029-02-26 U-1773 Drug product 2021-03-16 c2088c7a36db…2026-10-15 13:18:30 2026-09 N208437-001 9789270 2030-10-30 Drug product 2018-01-02 c2088c7a36db…2026-10-15 13:18:30 2026-09 N208437-001 9168556 2032-09-01 Drug product 2018-01-02 c2088c7a36db…2026-10-15 13:18:30 2026-09 N208437-001 9604018 2033-05-16 Drug product 2018-01-02 c2088c7a36db…2026-10-15 13:18:30 2026-09 N208437-001 10376661 2035-09-14 Drug product 2019-09-05 c2088c7a36db…2026-10-15 13:18:30 2026-09 N208437-001 10688518 2036-11-12 Drug product 2020-06-30 c2088c7a36db…2026-10-15 13:18:30 2026-09 N208437-001 10744277 2036-12-07 U-2941 Drug product 2020-09-01 c2088c7a36db…2026-09-14 22:38:34 2026-08 N208437-001 11278683 2026-08-16 Drug product 2022-03-25 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208437-001 9265900 2028-12-07 Drug product 2018-01-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208437-001 10940110 2029-02-26 U-1773 Drug product 2021-03-16 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208437-001 9789270 2030-10-30 Drug product 2018-01-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208437-001 9168556 2032-09-01 Drug product 2018-01-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208437-001 9604018 2033-05-16 Drug product 2018-01-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208437-001 10376661 2035-09-14 Drug product 2019-09-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208437-001 10688518 2036-11-12 Drug product 2020-06-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208437-001 10744277 2036-12-07 U-2941 Drug product 2020-09-01 84e616aacf4f…2026-08-18 06:07:40 2026-07 N208437-001 11278683 2026-08-16 Drug product 2022-03-25 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208437-001 9265900 2028-12-07 Drug product 2018-01-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208437-001 10940110 2029-02-26 U-1773 Drug product 2021-03-16 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208437-001 9789270 2030-10-30 Drug product 2018-01-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208437-001 9168556 2032-09-01 Drug product 2018-01-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208437-001 9604018 2033-05-16 Drug product 2018-01-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208437-001 10376661 2035-09-14 Drug product 2019-09-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208437-001 10688518 2036-11-12 Drug product 2020-06-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208437-001 10744277 2036-12-07 U-2941 Drug product 2020-09-01 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N208437-001 11278683 2026-08-16 Drug product 2022-03-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208437-001 9265900 2028-12-07 Drug product 2018-01-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208437-001 10940110 2029-02-26 U-1773 Drug product 2021-03-16 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208437-001 9789270 2030-10-30 Drug product 2018-01-02 011fe1cb6892…
Observed Orange Book exclusivity history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 60940-024-01 60940002401 432 POUCH in 1 CARTON (60940-024-01) > 2 VIAL in 1 POUCH > 1 mL in 1 VIAL 432 pouch 2017-12-05 0000-00-00 No No Current